PASTE Genome Editing via Nickase and Reverse Transcriptase

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current genome editing tools, such as CRISPR-Cas systems, rely on cellular repair mechanisms which are error-prone and inefficient for precise gene integration, limiting the effectiveness of programmable gene editing and delivery.

Innovation Solution

The method involves using a DNA binding nuclease with nickase activity linked to a reverse transcriptase domain, guided by a guide RNA to target specific genomic locations for site-specific integration of nucleic acids, enabling precise incorporation of nucleic acids into the genome through integration enzymes like Cre or Bxb1 integrase.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If CRISPR-Cas systems are used for genome editing, then programmable DNA interference is achieved with minimal requirements, but the process relies on error-prone cellular repair mechanisms that limit precision

Engineering Contradiction:
ImproveprogrammabilityVSAvoidintegration accuracy
Core Design Contradiction:
Ease of manufactureVSManufacturing precision

Solution Approach 1:

The system divides the integration process into two independent modules: (1) a DNA binding nuclease with nickase activity that creates a nick at the target site, and (2) a reverse transcriptase domain that performs site-specific integration of the nucleic acid. This segmentation allows each module to perform its function optimally without relying on error-prone cellular repair mechanisms.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces a guide RNA as an intermediary that directs the DNA binding nuclease to the specific genomic location. The guide RNA mediates between the programmable element and the target DNA, enabling precise targeting while the reverse transcriptase domain ensures accurate integration at the targeted site.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If cellular repair mechanisms are used for DNA repair, then DNA double strand breaks are repaired, but the process is error-prone and generates random indels causing frame shift mutations

Engineering Contradiction:
Improverepair capabilityVSAvoidmutation accuracy
Core Design Contradiction:
ReliabilityVSManufacturing precision

Solution Approach 1:

The patent replaces the error-prone cellular repair mechanisms (NHEJ and HR) with an engineered reverse transcriptase domain that performs site-specific integration. This substitution eliminates reliance on the cell's natural repair pathways and provides controlled, precise integration at the targeted genomic location.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The system changes the fundamental parameter of DNA repair from stochastic cellular processes to a programmable enzymatic reaction. The reverse transcriptase domain uses a template-guided mechanism to ensure accurate integration, transforming the repair process from error-prone to highly precise.

Inventive Principle:
Principle #35Parameter changes

3Manufacturing precision

If homology-directed repair is enhanced by fusion proteins or overlapping homology arms, then precise repairing capability is improved, but the process still relies on host DNA repair systems

Engineering Contradiction:
Improverepair precisionVSAvoidsystem complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent extracts the integration function from the host DNA repair systems entirely. By using a DNA binding nuclease with nickase activity combined with a reverse transcriptase domain, the system performs site-specific integration independently of cellular repair pathways, eliminating the need for complex fusion proteins or overlapping homology arms.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for efficient and precise site-specific integration of nucleic acids into the genome, reducing errors and improving the accuracy of gene editing, facilitating the treatment of diseases and diagnostics.

Implementation Method 1

the reverse transcriptase domain incorporates the integration sequence of the gRNA into the nicked site, thereby providing the integration site at the desired location of the cell genome

Methodology Applied
Scientific EffectReverse transcription:

Implementation Method 2

the DNA binding nuclease nicks a strand of the cell genome

Methodology Applied
Scientific EffectNicking:

Implementation Method 3

the integration enzyme incorporates the nucleic acid into the cell genome at the integration site by integration, recombination, or reverse transcription

Methodology Applied
Scientific EffectIntegration:

Implementation Method 4

the integration enzyme incorporates the nucleic acid into the cell genome at the integration site by integration, recombination, or reverse transcription

Methodology Applied
Scientific EffectRecombination:

Data Source

PatentUS20250092390A1Systems, methods, and compositions for site-specific genetic engineering using programmable addition via site-specific targeting elements (PASTE)
Publication Date: 2025.03.20 MASSACHUSETTS INST OF TECH
  • US20250092390A1 patent drawing
  • US20250092390A1 patent drawing
  • US20250092390A1 patent drawing

AI summary

This disclosure provides systems, methods, and compositions for site-specific genetic engineering using Programmable Addition via Site-Specific Targeting Elements (PASTE). PASTE comprises the addition of an integration site into a target genome followed by the insertion of one or more genes of interest or one or more nucleic acid sequences of interest at the site. PASTE combines gene editing technologies and integrase technologies to achieve unidirectional incorporation of genes in a genome for the treatment of diseases and diagnosis of disease.